For the cumulative first quarter of the fiscal year ending March 2027, Omikenshi recognized an extraordinary loss of 28 hundred million yen related to costs from restructuring measures, specifically the partial withdrawal from the cosmetics business. If earnings forecasts are revised, they will be disclosed promptly.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3111","jir_company_name":"Omikenshi Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-22","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/3111-20261022-02.pdf","jir_short_summary":"For the cumulative first quarter of the fiscal year ending March 2027, Omikenshi recognized an extraordinary loss of 28 hundred million yen related to costs from restructuring measures, specifically the partial withdrawal from the cosmetics business. If earnings forecasts are revised, they will be disclosed promptly.","jir_summary":"### Recognition of Extraordinary Loss and Background\nThis report communicates the recognition of an extraordinary loss in the cumulative first quarter of the fiscal year ending March 2027, specifying that 28 hundred million yen was recorded as costs associated with the partial withdrawal from the cosmetics business. The company states that this amount has already been factored into the previously disclosed consolidated earnings forecast and that any revisions to forecasts will be disclosed promptly.\n\n### Outlook and Impact\nBecause the extraordinary loss is described as already incorporated into forecasts, there is currently no publication of new sales or profit forecasts; the company will revise forecasts as necessary. The current IR material is primarily intended to provide information on the occurrence of the extraordinary loss and its treatment.","jir_financial_highlights":"Extraordinary loss (business withdrawal loss): 28 hundred million yen (Unknown)","jir_category":"","jir_hashtags":"#Omikenshi, #DisclosureUpdate, #ExtraordinaryLoss","jir_key_figures":"Extraordinary loss (business withdrawal loss): 28 hundred million yen","jir_meta_title":"Omikenshi \u2014 Notice of Extraordinary Loss Recognition | Q1 FY2027","jir_meta_description":"Omikenshi recognized an extraordinary loss of 28 hundred million yen in the cumulative first quarter of FY2027 related to the partial withdrawal from its cosmetics business. The release also describes the policy for any future forecast revisions.","jir_og_title":"Omikenshi | Notice of Extraordinary Loss Recognition","jir_og_description":"Recorded an extraordinary loss of 28 hundred million yen due to partial withdrawal from the cosmetics business. Any forecast revisions will be disclosed promptly.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":61299,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-133415","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n